Among these compounds, ganodermanontriol (289) also inhibited invasive behaviour (cell adhesion, cell migration and cell invasion) through the suppression of secretion of urokinase-plasminogen activator (uPA) and inhibited expression of the uPA receptor, suggesting that this compound can be a natural agent for treating invasive breast cancers [258]. This evidence concerns the gene PLAU and invasive breast carcinoma.